Cargando…

Combination antiretroviral therapy is associated with reduction in liver fibrosis scores in patients with HIV and HBV co-infection

BACKGROUND: Liver fibrosis is common in individuals with HIV/HBV co-infection, but whether cART could reverses liver fibrosis is unclear. METHODS: This was a retrospective observational study. Binary logistic regression was used to assess predictors of liver fibrosis in individuals with HIV/HBV co-i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Rongrong, Gui, Xien, Ke, Hengning, Xiong, Yong, Gao, Shicheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684625/ https://www.ncbi.nlm.nih.gov/pubmed/34924016 http://dx.doi.org/10.1186/s12981-021-00419-y

Ejemplares similares

Characteristics of refined lymphocyte subsets changes in people living with HIV/AIDS during antiretroviral therapy period: An observation from Wuhan, China
por: Yuan, Rui, et al.
Publicado: (2023)

Combination Antiretroviral Therapy Is Associated With Reduction in Liver Fibrosis Scores in HIV-1-Infected Subjects
por: Li, Yijia, et al.
Publicado: (2016)

Establishment and characterization of HBV-associated B lymphocytes with an immortalization potential
por: Qi, Xiaoying, et al.
Publicado: (2019)

Serum protein biomarkers for HCC risk prediction in HIV/HBV co-infected people: a clinical proteomic study using mass spectrometry
por: Ke, Hengning, et al.
Publicado: (2023)

Molecular diagnosis of central nervous system opportunistic infections and mortality in HIV-infected adults in Central China
por: Yang, Rongrong, et al.
Publicado: (2017)

Liver Fibrosis Regression Measured by Transient Elastography in Human Immunodeficiency Virus (HIV)-Hepatitis B Virus (HBV)-Coinfected Individuals on Long-Term HBV-Active Combination Antiretroviral Therapy
por: Audsley, Jennifer, et al.
Publicado: (2016)

Comparison of Clinical Characteristics of Patients with Asymptomatic vs Symptomatic Coronavirus Disease 2019 in Wuhan, China
por: Yang, Rongrong, et al.
Publicado: (2020)

Patients with respiratory symptoms are at greater risk of COVID-19 transmission
por: Yang, Rongrong, et al.
Publicado: (2020)

Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China
por: Gu, Lijun, et al.
Publicado: (2015)

Increased Prevalence of Liver Fibrosis and HIV Viremia among Patients with HIV, HBV, and Tuberculosis in Botswana
por: Phinius, Bonolo B., et al.
Publicado: (2020)

Abnormal Liver Stiffness Assessed Using Transient Elastography (Fibroscan®) in HIV-Infected Patients without HBV/HCV Coinfection Receiving Combined Antiretroviral Treatment
por: Han, Sang Hoon, et al.
Publicado: (2013)

HBV influence on Response to Antiretroviral Therapy in Horizontally HIV-HBV Coinfected Patient during Early Childhood
por: Niculescu, Irina, et al.
Publicado: (2013)

Two outbreaks of SARS-CoV-2 in department of surgery in a Wuhan hospital
por: Gao, Shicheng, et al.
Publicado: (2020)

High rates of hepatitis B virus (HBV) functional cure among HIV/HBV coinfected Chinese adults on antiretroviral therapy
por: Xia, Huan, et al.
Publicado: (2022)

Assessment of HBV flare in a randomized clinical trial in HIV/HBV coinfected subjects initiating HBV-active antiretroviral therapy in Thailand
por: Avihingsanon, Anchalee, et al.
Publicado: (2012)

Control of HBV infection in HIV/HBV co-infected patients treated with antiretroviral therapy – experience of Lodz Centre
por: Wlazłowska, Ewelina, et al.
Publicado: (2022)

Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C–Coinfected Persons
por: Brunet, Laurence, et al.
Publicado: (2016)

Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada?
por: Rana, Urvi, et al.
Publicado: (2019)

Proteomic and transcriptomic studies of HBV-associated liver fibrosis of an AAV-HBV-infected mouse model
por: Kan, Fangming, et al.
Publicado: (2017)

Liver fibrosis: concordance analysis between APRI and FIB-4 scores, evolution and predictors in a cohort of HIV patients without HCV and HBV infection
por: Mendeni, M, et al.
Publicado: (2010)

Liver Fibrosis during Antiretroviral Treatment in HIV-Infected Individuals. Truth or Tale?
por: Bakasis, Athanasios-Dimitrios, et al.
Publicado: (2021)

Liver fibrosis progression in a cohort of young HIV and HIV/ HBV co-infected patients: A longitudinal study using non-invasive APRI and Fib-4 scores
por: Iacob, Diana Gabriela, et al.
Publicado: (2022)

Cell death and pathological findings of the spleen in COVID-19 patients
por: Ping, Haiqin, et al.
Publicado: (2021)

Concordance between noninvasive assessments of fibrosis in patients with HIV/HIV+HBV infection
por: Dumea, Elena, et al.
Publicado: (2014)

Isolation and characterization of spontaneously immortalized B‐lymphocyte lines from HIV‐infected patients with and without non‐Hodgkin's Lymphoma
por: Zhuang, Ke, et al.
Publicado: (2019)

Management of HIV-2 resistance to antiretroviral therapy in a HIV-1/HIV-2/HBV co-infected patient
por: Cardoso, Margarida, et al.
Publicado: (2021)

Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV‐related hepatocellular carcinoma
por: Ding, Yezhou, et al.
Publicado: (2020)

Genetic polymorphisms associated with fatty liver disease and fibrosis in HIV positive patients receiving combined antiretroviral therapy (cART)
por: Dold, Leona, et al.
Publicado: (2017)

Association of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infection
por: Nagao, Yumiko, et al.
Publicado: (2014)

Brief Report: Impact of Antiretroviral Regimen on Pregnancy and Infant Outcomes in Women With HIV/ HBV Coinfection
por: Kiweewa, Flavia Matovu, et al.
Publicado: (2022)

Clinical Characteristics of Hospitalized Patients with SARS-CoV-2 and Hepatitis B Virus Co-infection
por: Chen, Xiaoping, et al.
Publicado: (2020)

HBV and HIV viral load but not microbial translocation or immune activation are associated with liver fibrosis among patients in South Africa
por: Maponga, Tongai Gibson, et al.
Publicado: (2018)

Long-Term Hepatitis B Virus (HBV) Response to Lamivudine-Containing Highly Active Antiretroviral Therapy in HIV-HBV Co-Infected Patients in Thailand
por: Khamduang, Woottichai, et al.
Publicado: (2012)

Acute Immune Reconstitution Inflammatory Syndrome-HBV Flare in an HIV/HBV Coinfected Patient After Antiretroviral Therapy Initiation: Case Report and Literature Review
por: Arshad, Iqra, et al.
Publicado: (2023)

Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy
por: Costantini, Andrea, et al.
Publicado: (2011)

A non-bioartificial liver support system combined with transplantation in HBV-related acute-on-chronic liver failure
por: Li, Peng, et al.
Publicado: (2021)

Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown
por: Iacob, Simona Alexandra, et al.
Publicado: (2022)

Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono‐infection under long‐term combined antiretroviral therapy
por: Perazzo, Hugo, et al.
Publicado: (2018)

Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative
por: Wang, Kai, et al.
Publicado: (2018)

Preventing mother to child transmission of HIV: lessons learned from China
por: Dong, Yu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i7tlsath0dmq0obd3lck84f6l0